Figure 2: Kaplan-Meier survival functions by early discontinuation or completion of endocrine therapy.

Figure 2 illustrates the Kaplan-Meier survival functions by early discontinuation or treatment completion among 4,600 premenopausal women (4,503 included in the final cohort did not have an event before 1.5 years after initiation of follow-up) diagnosed with breast cancer in Denmark (2002–2011) in the ProBe CaRe cohort.